INVICTA (4)
| Date | Circular | Tags | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
NSE adds six securities to ESM Stage I effective April 30, 2026, requiring 100% margin and shift from Rolling Settlement to Trade-for-Trade … | |||||||||||||||
NSE adds six securities to ESM Stage I effective April 30, 2026, requiring 100% margin and shift from Rolling Settlement to Trade-for-Trade segment from May 4, 2026.
| |||||||||||||||
Shareholding pattern disclosure for Invicta Diagnostic Limited filed under Regulation 31(1)(a) dated December 5, 2025, showing promoter … | |||||||||||||||
Shareholding pattern disclosure for Invicta Diagnostic Limited filed under Regulation 31(1)(a) dated December 5, 2025, showing promoter holding at 66.70% and public holding at 33.30%.
| |||||||||||||||
Invicta Diagnostic Limited securities will be transferred from trade for trade segment (ST) to rolling segment (SM) effective December 22, … | |||||||||||||||
Invicta Diagnostic Limited securities will be transferred from trade for trade segment (ST) to rolling segment (SM) effective December 22, 2025.
| |||||||||||||||
NSE announces listing of Invicta Diagnostic Limited equity shares on EMERGE SME Platform effective December 08, 2025 with symbol INVICTA in … | |||||||||||||||
NSE announces listing of Invicta Diagnostic Limited equity shares on EMERGE SME Platform effective December 08, 2025 with symbol INVICTA in Trade for Trade Surveillance Segment.
| |||||||||||||||